Fibrogen, Inc.
  • About Us
    • Company Overview
    • Leadership
    • Investors
    • Strategic Alliances
    • Contacts
    • FibroGen Europe
  • Clinical
    • Current Trials
  • Research & Development
    • Hypoxia-Inducible Factor
      HIF Biology
       
      HIF-PHI Therapy
       
      Anemia
       
      Cytoprotection/Inflammation
    • Connective Tissue Growth Factor
      CTGF Biology
       
      Anti-CTGF Therapy
       
      Chronic Kidney Disease
       
      Fibrotic Disease
       
      Cancer
    • Recombinant Human Collagen & Gelatin
  • News & Events
    • Publications
    • Press Releases
    • Events
    • Email Sign up
  • Careers
    • Job Search
    • Notice to Search Firms and Recruiters
search
 

Press Releases


View Archive: 2010  |  2009  |  2008  |  2007  |  2006  |  2005  |  2004  |  2003

8.25.10
FibroGen Announces Results of 2-Year Study Demonstrating that Biosynthetic Corneas Formulated with Recombinant Human Type III Collagen Restore Vision and Promote Nerve Regeneration

5.25.10
Two Join Board of Directors of FibroGen, Inc.

5.17.10
FibroGen Reports Preclinical Data Showing that FG-3019 Reversed the Process of Fibrosis in the Lung

Publications
 
Press Releases
 
Events
 
Email Sign up
   

 
© 2010 FibroGen, Inc. All rights reserved.
HomeContact UsPrivacy PolicyTerms and ConditionsSite Map